Provided are a novel compound and a hydrogen-bonding material treatment agent that are useful for treating various hydrogen-bonding materials such as biological samples. They are an organic ammonium salt and a hydrogen-bonding material treatment agent containing the same. The organic ammonium salt is solid at 25 C., and contains an anion and an ammonium cation represented by the following formula (I):

N.sup.R.sub.nH.sub.4-n(I)

wherein R independently represents, for example, a hydroxyalkyl group in which there is at least one hydroxy group, an alkyl moiety is a linear or branched moiety having 1 to 10 carbon atoms, and the alkyl moiety may contain an oxygen atom(s), and n represents an integer of 0 to 4.

Provided are a novel compound and a hydrogen-bonding material treatment agent that are useful for treating various hydrogen-bonding materials such as biological samples. They are an organic ammonium salt and a hydrogen-bonding material treatment agent containing the same. The organic ammonium salt is solid at 25 C., and contains an anion and an ammonium cation represented by the following formula (I):

N.sup.R.sub.nH.sub.4-n(I)

wherein R independently represents, for example, a hydroxyalkyl group in which there is at least one hydroxy group, an alkyl moiety is a linear or branched moiety having 1 to 10 carbon atoms, and the alkyl moiety may contain an oxygen atom(s), and n represents an integer of 0 to 4.

The disclosure generally relates to a system for perfusing an ex-vivo liver including a pump configured to pump a perfusion fluid through a perfusion circuit, the pump in fluid communication with a hepatic artery interface and a portal vein interface; an oxygenator; a heater; an inferior vena cava interface in fluid communication with an inferior vena cava of the ex-vivo liver; and a reservoir configured to receive the perfusion fluid from the inferior vena cava of the ex-vivo liver and store a volume of fluid.

The invention relates to a mixture of polyoxymethylene dialkyl ethers (POM) having a specific molecular distribution of n as well as its preparation method. The invention also relates to a composition comprising: a) a mixture of polyoxymethylene dialkyl ethers (POM) having a restricted specific molecular distribution b) at least one biocidal agent c) at least one pro-penetrating agent d) at least one dye e) optionally, another additive and water as diluent, It also relates to a non-therapeutic method of preserving and/or embalming a dead human or animal body using the composition, such as the use of this composition for anatomopathological purposes.

The invention relates to a mixture of polyoxymethylene dialkyl ethers (POM) having a specific molecular distribution of n as well as its preparation method. The invention also relates to a composition comprising: a) a mixture of polyoxymethylene dialkyl ethers (POM) having a restricted specific molecular distribution b) at least one biocidal agent c) at least one pro-penetrating agent d) at least one dye e) optionally, another additive and water as diluent, It also relates to a non-therapeutic method of preserving and/or embalming a dead human or animal body using the composition, such as the use of this composition for anatomopathological purposes.

The invention generally relates to systems, methods, and devices for ex vivo organ care. More particularly, in various embodiments, the invention relates to caring for a liver ex vivo at physiologic or near-physiologic conditions.

The present disclosure relates to, at least, a vacuum-assisted method for infiltrating cadaver bone with a cryoprotectant and a method for rapidly warming the cryopreserved cadaver bone for bone marrow processing.

The present invention relates to a method to treat insects in order to produce a human nutrition and/or an animal feed. The treatment involves at reducing and preferably stopping the autolysis of the insects, preferably using a cooling treatment step. The present invention further relates to a line to process insects.

The present invention relates to a method to treat insects in order to produce a human nutrition and/or an animal feed. The treatment involves at reducing and preferably stopping the autolysis of the insects, preferably using a cooling treatment step. The present invention further relates to a line to process insects.

Presented is an airway organ bioreactor apparatus, and methods of use thereof, as well as bioartificial airway organs produced using the methods, and methods of treating subjects using the bioartificial airway organs. The bioreactor comprises: an organ chamber: an ingres line connecting the organ chamber and a reservoir system and comprising an arterial line, a venous line and a tracheal line; an egress line connecting the chamber and the reservoir system, pumps in ingress and egress lines; a controller to control fluid exchange; a chamber pressure sensor connected to the organ chamber.